RT Journal Article
SR Electronic
T1 1527 ENB-003, an ETBR antagonist, in combination with pembrolizumab, shows promise in microsatellite stable platinum refractory/resistant ovarian cancer: data from the ENBOLDEN-101 phase 1B study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1752
OP A1752
DO 10.1136/jitc-2023-SITC2023.1527
VO 11
IS Suppl 2
A1 Jamal, Sumayah
A1 Selvaggi, Giovanni
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1752.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.